170 related articles for article (PubMed ID: 26289557)
1. Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients.
Zhang D; Yao Y; Qian J; Huang J
Med Sci Monit; 2015 Aug; 21():2439-45. PubMed ID: 26289557
[TBL] [Abstract][Full Text] [Related]
2. Effects of levosimendan/furosemide infusion on plasma brain natriuretic peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients.
Feola M; Lombardo E; Taglieri C; Vallauri P; Piccolo S; Valle R
Med Sci Monit; 2011 Feb; 17(3):PI7-13. PubMed ID: 21358614
[TBL] [Abstract][Full Text] [Related]
3. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
[TBL] [Abstract][Full Text] [Related]
4. Short-term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure.
Kurt IH; Yavuzer K; Batur MK
Heart Vessels; 2010 Sep; 25(5):392-9. PubMed ID: 20676961
[TBL] [Abstract][Full Text] [Related]
5. Effects of levosimendan on TNF-alpha, BNP and MMP-1 in patients with heart failure with anemia.
Büyüklü M; Kürüm AT; Tatlý E; Set T
Arq Bras Cardiol; 2012 Jul; 99(1):659-64. PubMed ID: 22735864
[TBL] [Abstract][Full Text] [Related]
6. Effects of levosimendan on heart failure in normotensive patients: does loading dose matter?
Palmerini E; Söderberg S; Mondillo S; Favilli R; Lunghetti S
Acute Card Care; 2015 Mar; 17(1):14-9. PubMed ID: 25806830
[TBL] [Abstract][Full Text] [Related]
7. Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure.
Parissis JT; Adamopoulos S; Farmakis D; Filippatos G; Paraskevaidis I; Panou F; Iliodromitis E; Kremastinos DT
Heart; 2006 Dec; 92(12):1768-72. PubMed ID: 17105880
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan in outpatients with advanced heart failure: Single-center experience of 200 intermittent perfusions.
Ferreira Reis J; Valentim Gonçalves A; Ilhão Moreira R; Pereira da Silva T; Timóteo AT; Pombo D; Carvalho T; Correia C; Santos C; Cruz Ferreira R
Rev Port Cardiol; 2023 Apr; 42(4):335-343. PubMed ID: 36634758
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up.
Sargento L; Brito D; Matias JS; Madeira H
Rev Port Cardiol; 2007; 26(7-8):717-26. PubMed ID: 17939581
[TBL] [Abstract][Full Text] [Related]
10. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
[TBL] [Abstract][Full Text] [Related]
11. Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure.
Lunghetti S; Palmerini E; Urselli R; Maffei S; Guarino E; Focardi M; Mondillo S; Favilli R
Cardiol J; 2011; 18(5):532-7. PubMed ID: 21947989
[TBL] [Abstract][Full Text] [Related]
12. Value of IGF-I levels in the evaluation of response to treatment with levosimendan in patients with severe heart failure.
Işık S; Cetin M; Ciçekçioğlu H; Uçar O; Çetin ZG; Ozuğuz U; Bakır F; Berker D; Güler S
Anadolu Kardiyol Derg; 2011 Sep; 11(6):523-9. PubMed ID: 21821501
[TBL] [Abstract][Full Text] [Related]
13. Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial.
McKelvie RS; Komajda M; McMurray J; Zile M; Ptaszynska A; Donovan M; Carson P; Massie BM;
J Card Fail; 2010 Feb; 16(2):128-34. PubMed ID: 20142024
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure.
Cetin M; Uçar O; Cicekçioğlu H; Güven Cetin Z; Sahin M; Vasfi Ulusoy F; Aydoğdu S
Acta Cardiol; 2012 Jun; 67(3):317-23. PubMed ID: 22870740
[TBL] [Abstract][Full Text] [Related]
16. N-terminal-pro-B-type natriuretic peptide (NT-proBNP): reference range for Chinese apparently healthy people and clinical performance in Chinese elderly patients with heart failure.
Shi X; Xu G; Xia T; Song Y; Lin Q
Clin Chim Acta; 2005 Oct; 360(1-2):122-7. PubMed ID: 16002063
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of levosimendan in elderly patients with severe heart failure].
Wang YB; Yu YH; Gong SJ; Yan J; Wang Y
Zhonghua Nei Ke Za Zhi; 2020 Jun; 59(6):433-438. PubMed ID: 32486583
[No Abstract] [Full Text] [Related]
18. Short-term efficacy and safety of levosimendan in patients with chronic systolic heart failure.
Cui XR; Yang XH; Li RB; Wang D; Jia M; Bai L; Zhang JD
Cardiovasc J Afr; 2020; 31(4):196-200. PubMed ID: 32555927
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.
Comín-Colet J; Manito N; Segovia-Cubero J; Delgado J; García Pinilla JM; Almenar L; Crespo-Leiro MG; Sionis A; Blasco T; Pascual-Figal D; Gonzalez-Vilchez F; Lambert-Rodríguez JL; Grau M; Bruguera J;
Eur J Heart Fail; 2018 Jul; 20(7):1128-1136. PubMed ID: 29405611
[TBL] [Abstract][Full Text] [Related]
20. The prolonged lowering effect of levosimendan on brain natriuretic peptide levels in patients with decompansated heart failure: clinical implications.
Celik T; Iyisoy A; Yuksel UC; Kardesoglu E
Int J Cardiol; 2008 Aug; 128(1):97-9; authr reply 100-2. PubMed ID: 18501448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
